In an SS model, inhibition of HMGB1 improved xerostomia triggered by SS by suppressing the HMGB1/TLR4/NF‐κB signaling pathway and upregulating AQP5 expression [180]. This evidence concerns the gene TLR4 and synovial sarcoma.